✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹11,202 Cr.
P/E
66.56

Key Ratios

Market cap
Market cap
11,202 Cr
PE
PE
66.56
Prom Holding
Prom Holding
71.27 %
ROE (%)
ROE (%)
66.30
ROCE (%)
ROCE (%)
94.77
Div Yield (%)
Div Yield (%)
1.13
Sales
Sales
667 Cr
OPM (%)
OPM (%)
37.87 %
Debt to Equity
Debt to Equity
-
About
Sanofi Consumer Healthcare India, based in Mumbai, is a company engaged in manufacturing and t… Read more
Low
4212
52W Range
High
5895
  • Sanofi Cons. Health
  • Granules India
  • Medplus Health Servi

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

3 Yes

Positive for this company

1 Neutral

Neutral for this company

2 No

Negative for this company

10 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Sanofi Consumer Healthcare India Ltd. Business

Sanofi Consumer Healthcare India was incorporated and domiciled in India on May 10, 2023, having its registered office at Vikhroli East, Mumbai. It is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company also has various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily in India.

Sanofi Cons. Health major competitors are Granules India, Medplus Health Servi, Acutaas Chemicals, Procter&Gamble Healt, Marksans Pharma, Alivus Life Sciences, Sanofi India.
Market Cap of Sanofi Cons. Health is ₹11,202 Crs.
While the median market cap of its peers are ₹10,917 Crs.

Sanofi Cons. Health seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material